Jim Simons Statera Biopharma, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.08 - $0.23 $50,764 - $145,947	-634,556 Reduced 46.76%	722,390 $59,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $0.28 $36,307 - $78,200	-279,289 Reduced 17.07%	1,356,946 $176,000
Q2 2022 Aug 12, 2022	BUY	$0.21 - $0.38 $307,506 - $556,440	1,464,317 Added 851.75%	1,636,235 $466,000
Q1 2022 May 13, 2022	SELL	$0.31 - $2.27 $10,576 - $77,445	-34,117 Reduced 16.56%	171,918 $54,000
Q4 2021 Feb 11, 2022	BUY	$2.01 - $4.08 $184,592 - $374,694	91,837 Added 80.42%	206,035 $474,000
Q3 2021 Nov 12, 2021	BUY	$2.29 - $6.24 $261,513 - $712,595	114,198 New	114,198 $264,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.